The common
inhalation anesthetic isoflurane has been shown to induce apoptosis, which then leads to accumulation of
beta-amyloid protein, the hallmark feature of
Alzheimer disease neuropathogenesis. The underlying molecular mechanism of the
isoflurane-induced apoptosis is largely unknown. We, therefore, set out to assess whether
isoflurane can induce apoptosis by regulating Bcl-2 family
proteins, enhancing
reactive oxygen species (ROS) accumulation, and activating the mitochondrial pathway of apoptosis. We performed these studies in cultured cells, primary neurons, and mice. Here we show for the first time that treatment with 2%
isoflurane for 6 h can increase pro-apoptotic factor Bax levels, decrease anti-apoptotic factor Bcl-2 levels, increase ROS accumulation, facilitate
cytochrome c release from the mitochondria to the cytosol, induce activation of
caspase-9 and
caspase-3, and finally cause apoptosis as compared with the control condition. We have further found that
isoflurane can increase the
mRNA levels of Bax and reduce the
mRNA levels of Bcl-2. The
isoflurane-induced ROS accumulation can be attenuated by the intracellular
calcium chelator BAPTA. Finally, the
anesthetic desflurane does not induce activation of mitochondrial pathway of apoptosis. These results suggest that
isoflurane may induce apoptosis through Bcl-2 family
proteins- and ROS-associated mitochondrial pathway of apoptosis. These findings, which have identified at least partially the molecular mechanism by which
isoflurane induces apoptosis, will promote more studies aimed at studying the potential neurotoxic effects of
anesthetics.